CDK4 and breast carcinoma: It has been [34] shown that miR-6775-3p can negatively regulate CDK4, CDK6, MMP17, and MMP24 levels in breast cancer cells by binding to the 3′UTR of their mRNAs, thereby inhibiting the proliferation, migration, and invasive abilities of breast cancer cells.